# EDGAR Filing Document

**Accession Number:** 0001577524
**File Stem:** 0001420506-25-002667
**Filing Date:** 2025-9
**Character Count:** 5002
**Document Hash:** 829d6d6ed8de45f61995de4c9bbe8744
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001420506-25-002667.hdr.sgml**: 20250902

**ACCESSION NUMBER**: 0001420506-25-002667

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250902

**EFFECTIVENESS DATE**: 20250902

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sarissa Capital Management LP
- **CENTRAL INDEX KEY:** 0001577524

**ORGANIZATION NAME:**
- **EIN:** 900924432
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-15935
- **FILM NUMBER:** 251283635

**BUSINESS ADDRESS:**
- **STREET 1:** 500 WEST PUTNAM AVENUE, SUITE 400
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 203-302-2330

**MAIL ADDRESS:**
- **STREET 1:** 500 WEST PUTNAM AVENUE, SUITE 400
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001577524

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Sarissa Capital Management LP

**Address:** 500 West Putnam Avenue, Greenwich, CT 06830

**Telephone number:** 203-302-2330

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-15935

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                 | CUSIP     | MEETING DATE   | VOTE DESCRIPTION       | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Lantheus Holdings, Inc.        | 516544103 | 05/01/2025     | Executive Compensation | SECTION 14A SAY-ON-PAY VOTES |          65128 |                0 | AGAINST     |                                    65128 | FOR                         |  |
| Amarin Corporation PLC         | 023111206 | 05/13/2025     | Executive Compensation | SECTION 14A SAY-ON-PAY VOTES |       24849623 |                0 | FOR         |                                 24849623 | FOR                         |  |
| Cytokinetics, Incorporated     | 23282W605 | 05/14/2025     | Executive Compensation | SECTION 14A SAY-ON-PAY VOTES |         600000 |                0 | AGAINST     |                                   600000 | FOR                         |  |
| Innoviva Inc                   | 45781M101 | 05/19/2025     | Executive Compensation | SECTION 14A SAY-ON-PAY VOTES |        2188500 |                0 | FOR         |                                  2188500 | FOR                         |  |
| Neurocrine Biosciences, Inc.   | 64125C109 | 05/21/2025     | Executive Compensation | SECTION 14A SAY-ON-PAY VOTES |         307434 |                0 | ABSTAIN     |                                   307434 | FOR                         |  |
| Neurocrine Biosciences, Inc.   | 64125C109 | 05/21/2025     | Executive Compensation | SECTION 14A SAY-ON-PAY VOTES |         307434 |                0 | FOR         |                                   307434 | FOR                         |  |
| Neurocrine Biosciences, Inc.   | 64125C109 | 05/21/2025     | Executive Compensation | SECTION 14A SAY-ON-PAY VOTES |         307434 |                0 | FOR         |                                   307434 | FOR                         |  |
| Ironwood Pharmaceuticals, Inc. | 46333X108 | 06/10/2025     | Executive Compensation | SECTION 14A SAY-ON-PAY VOTES |       13797028 |                0 | FOR         |                                 13797028 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Sarissa Capital Management LP

**By (Signature):** Alexander J. Denner, Ph.D.

**By (Printed Signature):** Alexander J. Denner, Ph.D.

**By (Title):** Chief Investment Officer

**Date:** 09/02/2025